Member Info for chester18

@thedoors

you are probably right a broker note can stir a share into life, problem here is the brokers are always trying to catch up to where the research on this board has already driven the price. Right now a broker note might be 22p but we are already on our way past that level.

It would be fantastic if the broker could be bold but they can't they have to be cautious. After the Newcrest quarterly at the end of this month maybe a quickly released broker note could be far enough ahead that it will cause an uplift in itself.

I really like positive surprises so let hope I'm total wrong ....... : )

Chester.

My dream road map towards Christmas post has had a good start, it is like I've put on a 'Lucky 63 Bet' and the first ones come in ...... : )

a) GH Presenting tomorrow. 21.5p --- CORRECT -----

b) Ariel Magnetics report. next 7/10 days. 23p
c) Scallywag Initial Report. 2/3 weeks. 33p
d) Newcrest Quarterly Report. 5 weeks. 38p
e) Kraken / London Initial Report. 6/7 weeks. 45p
f ) MMRE. 12/14 weeks. 52p

Ariel Magnetics next.. 23p ... What are the chances of a mid Tuesday morning 'GH' Special.....

Chester.

Just had a quick look at the todays trades and the MM's are doing a great job of mixing up the Buys & Sells but it does seem to me that there we are still seeing a steady flow of large sells. If I aqm right and they are all sells it is very unlikely to be Private Investors so I'm guessing that we will see another Holdings RNS at some point next week.

If there is a Holdings RNS and it turns out to show further accumulation by one of the big investors I would suggest that the MM's are playing all PI's like a fiddle.

Hopefully next week will through some light on the subject.......

Chester.

This RNS is a pivitol step towards the anticipated release of current Lab data.

As has already been said on here, todays news confirms the make up of the plasmid DNA, this is a really important stage in the progress towards the clinical trials. It doesn't say 'ok guys it works' but it does say we've seen enough evidence in our laboratory mouse models to commit to this formula.

One more thing from this release, those of us that have been here a while know for a fact that Prof Lindy Durrant does not move forward on a gut feeling it is always on concrete repeatable science.

Massively important key to the delivery of a our 2nd Gen vaccine.

Chester.

Hi BOJO2020

I'm sure that Chronocort is going through the European approval first quarter next year an then later to the FDA. DNL still need to sign up a US partner agreement for Chronocort which will probably be a second agreement with Eton.

Chester.

Hi Woodstock1970

Any long term holder of TRX have seen their original investment shredded, but, baring the pandemic shutting down all non-essential surgery in both the US and Europe, TRX are going to grow very rapidly once the 1st phase expansion is up and running. Right now the business is hampered by not having enough capacity so once that first bit is sorted they can get on with the second phase and then the third and so on.

The turnaround will probably begin early 2021 and should rise quickly so don't chuck in the towel just yet. We may even get earlier indications of improvements and we may even find out just who we have signed that deal with.

ATB

Chester.

Hi 6pots

Welcome and thank you for your thoughts.

Its good to have someone with M&A experience on the board and once the first phase of the San Antonio manufacturing facility is in full production we should begin to see a dramatic rise in turnover and move towards an operating profit. As you know TRX has a range of products that could dominate those niche spaces and will definitely attract attention from the sitting tenants.

Chester.

WE have 26 entries....... The * indicates pledges for ‘£25 Charity Donation’
Charity to be chosen by the 'Winner' who predicted the nearest SP to the actual Closing SP on Friday 1st October 2021.
The average guess is 1.09462p ( MCap £77.0m )

JonnyRod. 0.20p
Nomlungu. 0.30p*
Jurado. 0.42p
TheOldBee. 0.62p*
JoeSoap1. 0.68p*
MRK2020. 0.70p
ChrissyDude. 0.83p
Chester. 0.86p*
Stuofthetoon . 0.95p
G&M. 0.97p
KJM100K. 1.01p*
Scoobyrex. 1.08p
DoneK. 1.1p
Andysmi. 1.20p
theAccountant. 1.25p
LunchBoxBill. 1.21p*
Ohmni. 1.27p
HBomb5. 1.28p
Mark@1973. 1.30p
SC888. 1.31p
Messi10. 1.45p*
Owennoone. 1.48p
Shovel53. 1.57p
Smokey2. 1.68p
Sandhopper 1.75p
Icecool. 1.99p*

So we have an MCap range from £14m up to £ 122.5m, may as well say we have a good mix of 'Pessimists and Optimists'.

There is no statutory reason for TRX to give out any news over the next 3 months but if they decide to keep us shareholders informed we may get a 'Trading Update' late November / early December being six months from the May 21st Placement via Primary Bid. I think if we do have to endure another two months of 'radio silence' they will owe it to us all to say how the company is progressing and where they have been investing some of the placing cash.

Chester.

If this is the type of shareholder base that DNL currently have, thank goodness the decision was positive!!!

Yes revenues are still some time away but DNL have just been given the absolute best recommendation that money cannot buy. The FDA have approved their drug, I just don't think some understand how monumental that achievement is.

Apart from the payments that will now flow from Eton Pharma, this validation will help to win approvals in many more country's.

I think anyone who is prepared to invest here for the next 2 / 3 years is going to be handsomely rewarded. I also agree that over time the bulk of the shares will move into Institutional Investors hands.

Really glad to be on board with Diurnal and looking forward to the things to come.

Chester.

The value of the DNL business is going up just on the rise of Etons US share price.
We are doing very nicely both sides of the pond.

Chester.

Sorry, Hardman's new target price is 'risk adjusted' £2.23 per share.

Chester.

Hardman report on Diurnal has raised their unrisked valuation to £2.23 per share so they are saying that an MCap of £ 270m is where we should be on this news.

Huge upside on this share and people are bailing for a quick 10/15%

Chester.

Fantastic news, well done Diurnal great result after all their work and dedication to achieving this approval.

The company is now set up to grow hugely over the next 3/4 years.

Chester.

Hi Cadburyhill

I totally agree that TRX now have the potential to become a very serious business and I mean MCap exceeding £500m in four to five years time.

As you know Extremities is a division of Integra LifeSciences, Turnover 2019 $90 current first six months $37.7m.
They have been sold for $240m which is not to shabby due to the fact that even at $90m t/o they were still losing money.
The pandemic means they will not reach breakeven until end 2022 or end 2023.
From the proceeds of the sale Integra has to pay $41.5m to the Consortium of Focused Orthopaedists who help develop the range of products sold by Extremities.
Bottom line is Integra would not see a return from that division for a long time to come and it fits perfectly with S&N's future focus.

TRX should be in a much more stable position by next Summer and when they reach £90m ( 2023 full year ) turnover that should be producing around £30m profit if they are able to maintain a 40% margin. If added to that TRX are still growing fast then the MCap would already be heading towards £180 to £200m so what price would someone have to pay?

All good given that the current management keep fully focused on the growth of the business but not at the expense of the margin. The old saying "Turnover is Vanity - Profit is Sanity"...

Chester.

Hi cadburyhill,

Always appreciate your posts and thank you for posting this info on Smith and Nephew, I will do some reading on Extremities to see how it reflects on TRX.

I think when TRX hits £90m turnover they will be making a substantial profit if they are still maintaining a 40% ish profit margin. Extremities must have either very high costs or woefully low margins to be sold for so little.
As I say I will have a read up and come back more enlightened.

Chester.

Can we presume that the FDA will still make a decision today so we may hear later or will this now be deferred to 1.00pm tomorrow inline with when the US stock exchange opens and the FDA release their statements.

Chester.

Is anyone watching the FDA releases feed for info ?

Chester.

For RNS release go to :

https://www.londonstockexchange.com/news?tab=news-explorer

Chester.

Hi DMcG54

I'm sure all the Diurnal management and staff are all on pins.
Must be more nerve racking for them as well.

Lets be positive, its a fantastic new innovation and is a huge step up from what kiddies have to face with continual injections and the like. So given that DNL have done everything correct it would be wrong for the FDA to delay the process on a wrongly dotted i .

CityTTrader said we will probably have to wait for the US to wake up and then the FDA will issue their decision after 2.30pm which is probably correct. So I'm off out for four hours and will check back after 2.30pm.

Laters ............. : )

Chester.

@Jurado

Added........ I'll put the whole list up on Thursday.

Chester.